Cargando…
Pro-angiogenic Role of Danqi Pill Through Activating Fatty Acids Oxidation Pathway Against Coronary Artery Disease
Coronary artery disease (CAD) is one of the leading causes of deaths worldwide. Energy metabolism disorders, including a reduction in fatty acids oxidation and upregulation of glycolysis pathway, are involved in the process of CAD. Therapeutic angiogenesis has become a promising treatment for CAD. T...
Autores principales: | Jiao, Shihong, Tang, Binghua, Wang, Yong, Li, Chun, Zeng, Zifan, Cui, Lixia, Zhang, Xuefeng, Shao, Mingyan, Guo, Dongqing, Wang, Qiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289089/ https://www.ncbi.nlm.nih.gov/pubmed/30564122 http://dx.doi.org/10.3389/fphar.2018.01414 |
Ejemplares similares
-
Multitarget Effects of Danqi Pill on Global Gene Expression Changes in Myocardial Ischemia
por: Wang, Qiyan, et al.
Publicado: (2018) -
Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway
por: Zhang, Qian, et al.
Publicado: (2020) -
Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease
por: Chang, Hong, et al.
Publicado: (2016) -
DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4
por: Wang, Yong, et al.
Publicado: (2014) -
Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway
por: Wang, Yong, et al.
Publicado: (2015)